AnaBios CEO Andre Ghetti has been invited to present at the 8th Japanese Safety Pharmacology Society Annual Meeting, taking place at the University of Tokyo, February 10th – 11th, 2017. Dr. Ghetti will speak on “Adult Human Ex-Vivo Cardiac Models for Preclinical Safety Assessment.”